We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Cvs Group Plc | LSE:CVSG | London | Ordinary Share | GB00B2863827 | ORD 0.2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-20.50 | -2.01% | 998.50 | 995.50 | 1,002.00 | 1,040.00 | 990.00 | 1,040.00 | 228,094 | 13:27:23 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Veterinary Svcs-animal Specs | 608.3M | 41.9M | 0.5843 | 16.99 | 711.75M |
Date | Subject | Author | Discuss |
---|---|---|---|
22/3/2024 07:43 | "As a result of Brexit, the process for applying to work in the UK has become much more complicated, preventing many European candidates from easily migrating. This has contributed to the huge fall of 68% in qualified EU-based vets moving to the UK between the years 2019-2021. According to Charles Hartwell, CEO of a provider of public health veterinary services Eville & Jones, prior to Brexit, there was a need for approximately 2,000 vets each year – with 1,000 produced by the UK vet school system. This created a gap of about 1,000 professionals filled by vets from the EU, although, which, according to, finished abruptly with Brexit. " If they arrive in a dingy they'll be fine! | bulltradept | |
21/3/2024 16:30 | I think roddyb is short. It is supply and demand isn't it. All the foreign vets have gone home thanks to brexit. There is massive shortage of vets in the UK www.themedicportal.c | undervaluedassets | |
21/3/2024 08:48 | Added a few more. | lomax99 | |
21/3/2024 08:14 | Looks like you are right, Mr Market is looking for clarity. | bulltradept | |
18/3/2024 13:38 | I am hoping this will recover but there are very valid concerns as to how these companies price their services and fail to disclose pricing and dissuade pet owners from shopping around. The CMA are going to land some blows just as they did with Dignity Funeral services. Management will be scared to do share buybacks during the CMA investigation and probably scared to pay an increased dividend? They will certainly be delaying purchasing any more UK vet practices. Not looking good for the next 6 months. | roddyb | |
16/3/2024 15:18 | Re 902 above, it'd be interesting to know Liberum's recommendation & target price now, now that the CMA have decided to proceed. | dogwalker | |
16/3/2024 12:05 | IVC Evidensia are the biggest player in the UK market with around 1000 UK locations (2500 worldwide). They are a private equity outfit, therefore, not mentioned in press. But are more then 5x the size of cvs (ww). To me, the trend towards larger groups is all about economies of scale, not about exploiting a monopoly (most small vets have a near monopoly in their location anyway). I think it is likely any competition authority will come to the same conclusion. Making these practices cut their price will just close the smaller, less efficient vets and not help the market. For those reasons I think this will recover over the next few months and have invested here yesterday at 1005. This share price drop could also attract a speculative bid imho. The USA are well ahead of UK, Europe, Australia with large vet groups. I am sure they will be looking at cvsg with interest now!! Huge companies such as Mars (already own 180 uk practices), Walmart etc are in this sector. | wallywoo | |
16/3/2024 06:37 | CVS discount is too high, says LiberumThe discount at which veterinary group CVS (CVSG) trades is 'too high', given the competition watchdog's review into vet practices is likely to prove there is no case to answer, says Liberum.Analyst Seb Jantet retained his 'buy' recommendation and target price of £22 on the stock, which gained 1.4% to £14.92 at the end of last week after its interim results. The shares have shed 21% over the year following the Competitions & Markets Authority (CMA) decision to investigate whether vets were providing consumers with value for money.Jantet said there was not a lot of new information in the result but added that 'we are still waiting for the most important piece of information, being the CMA's initial decision which is still expected in early 2024'.'While the shares have recovered a little over the last few months, they are still trading on undemanding multiples both in absolute terms and in relation to historic ratings, on a current year 2024 embedded value to pre-tax profit multiple of 9.9 times,' he said.'While we accept that the CMA uncertainty warrants a discount over the historic rating of around 15 times, the discount looks too high to us, especially given our view that there is a good chance the CMA will conclude there isn't a case to answer when it next updates.' | lomax99 | |
15/3/2024 18:40 | Well that took another hammering today. Below £10 for first time in 4 yrs. Timed my buy badly a couple of weeks ago. There seems a lot of pessimism priced in now. Suspect a gradual recovery will happen but not until more CMA clarity. | wad collector | |
15/3/2024 09:59 | overhang cleared? 50k odd sell reported | tsmith2 | |
13/3/2024 17:58 | Mmmm got to stay above a tenner... | bulltradept | |
13/3/2024 12:14 | To add to that CVS also own one of the biggest online pet pharmacies (Animed) so they have that base covered too. | travis2 | |
13/3/2024 11:51 | Looking good. | babbler | |
13/3/2024 06:50 | It cost me just my excess when my pets died not long ago. The insurance paid the bills. Only thing they don't really pay for is standard prescriptions. If you can't handle the bills that's what insurance is for in this case. | babbler | |
13/3/2024 06:48 | Totally agree. In my area there are quite a few vets most or all have a waiting list of at least a month and quite a few are independent. Competition is high and there aren't enough vets. Supply and demand means prices are high. That's life. If there was no demand prices would fall. | babbler | |
13/3/2024 05:29 | Well we now have a 2017 share price And in 2017 the company had EPS of 18p, profits of 14 million and a 271 million turnover. Is that what we should expect? instead of the pencilled 80-90p in earnings on 50-90 million in profit on a turnover of 670 million? I do not see that being the case... Ergo .. cheap The market panicked today. In the past, I have done well out of buying into panics. | undervaluedassets | |
12/3/2024 21:18 | The prescription issue is a bit of a red herring. If more owners take the prescriptions away and get them cheaper from suppliers then the practices will have to recoup that loss by increasing other fees . Unless the practices make reasonable profit then the vets will walk away . Exactly how the charging structure is formulated does not get round that problem. It is not clear from the CMA report how widespread they think the monopolistic problem is. Doubtless there will be some posturing from the CMA but unless most of the CVS practices are in isolated areas without competition, then they will be in a similar boat to all the practices. | wad collector | |
12/3/2024 19:28 | Point taken, looks as though the CMA may enforce some action on prescriptions, possibly also lab and radiology investigations and cremations. Some groups may have to divest some surgeries in certain areas. | 1c3479z | |
12/3/2024 19:02 | My dog is on heart medication, his £400 annual insurance (which is meant to help cover the cost of professional time, investigations,surge | aberloon2 | |
12/3/2024 18:39 | general public spoiled to an extent by the NHS being 'free' and don't appreciate the cost of professional time, investigations,surge | 1c3479z | |
12/3/2024 16:21 | Appreciated Dave. | essentialinvestor | |
12/3/2024 16:14 | Hi EII'd pencilled in 95p to 100p eps here and it's historically been highly rated (average PE circa 23x although read somewhere the median is a lot higher?). The CMA issue could change that growth rating, they've achieved 33% CAGR in eps over the last 6 years or so and IMO such a high rating was justified, if their growth is impacted then pick a number!. Would sooner keep this in my watch list now and see how it pans out. It's a binary bet at the moment. | disc0dave46 | |
12/3/2024 16:09 | BabblerIf you read the PETS response it comes across a lot more positively IMO, that they have nothing to be concerned with and it won't impact on their growth. Hence I guess the reason for only a 3% drop in share price I'd still contend that admitting they have plans to address issues says a lot, and not reaffirming that their growth won't be impacted suggests it possibly could be. Yes glass half empty opinions but the market seems to take the same view. | disc0dave46 | |
12/3/2024 16:02 | been buying all day. The business still stands pet owners don't stop going cos of the CMA Will be viewed storm in a teacup in few years time. And once in lifetime buy opp. 16 million pet owners still need their pets looking after. | undervaluedassets | |
12/3/2024 15:41 | dipped toes at £11 | tsmith2 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions